ENPP2 and breast carcinoma: If these effects prove to be temporally robust, unlike those seen with DEX and other glucocorticoids in RT-induced lung inflammatory mediator responses, pneumonitis and fibrosis in rodent models [44,82,83], then this approach may be especially relevant in the treatment of breast cancer with RT since adipocytes are the major source of ATX in the breast.